Treadmill exercise in claudicants on aspirin results in improved antioxidant status but only minimal platelet activation

Platelets. 2005 Dec;16(8):446-52. doi: 10.1080/09537100500128740.

Abstract

The consequence of exercise on platelets remains controversial and adverse effects may result from repeated ischaemia reperfusion injury. We investigated platelet activation (platelet P-selectin (PS), and activated glycoprotein (Gp) IIb/IIIa), platelet-monocyte aggregates (PMA) and total plasma antioxidant status (TPAS) in claudicants after exercise. Twenty claudicants, taking 75 mg of aspirin daily, were subjected to repeated treadmill testing (3 km/h, 10% inclination). Blood was sampled before and after exercise. Activated GpIIb/IIIa, PS and PMA were quantified with flow cytometry. TPAS was quantified using a decolourisation assay. Percent positive cells for PS (pre-exercise 3.76% vs. 40 min post-exercise 4.10%; P < 0.05) and platelet-monocyte aggregates (pre-exercise: 25.31% vs. 40 min post-exercise 26.99%; P < 0.05) were significantly higher after exercise. Relative median fluorescence (RMF) for activated GpIIb/IIIa was significantly higher 40 min after exercise (pre-exercise: 3.04 vs. 40 min post-exercise: 4.01; P < 0.05). TPAS was significantly higher post-exercise (pre-exercise: 1.31 mmol/l vs. 1 min post-exercise: 1.40 mmol/l and 40 min post-exercise: 1.38 mmol/l; P < 0.01). Following moderate exercise, 'aspirin treated claudicants' show marginal platelet activation, PMA formation and a favourable improvement in antioxidant status. Further studies are required to assess the effect of additional antiplatelet agents and the significance of platelet-monocyte interactions. The possibility that aspirin contributes to the TPAS changes following exercise needs to be investigated.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Antioxidants / analysis
  • Aspirin / administration & dosage*
  • Case-Control Studies
  • Exercise Test* / adverse effects
  • Female
  • Humans
  • Intermittent Claudication / blood*
  • Intermittent Claudication / drug therapy
  • Male
  • Middle Aged
  • Oxidation-Reduction / drug effects
  • P-Selectin / blood
  • Phenols
  • Plant Extracts
  • Platelet Aggregation / drug effects*
  • Platelet Aggregation Inhibitors / administration & dosage*
  • Platelet Glycoprotein GPIIb-IIIa Complex / analysis
  • Reperfusion Injury / blood*
  • Reperfusion Injury / etiology

Substances

  • Antioxidants
  • P-Selectin
  • Phenols
  • Plant Extracts
  • Platelet Aggregation Inhibitors
  • Platelet Glycoprotein GPIIb-IIIa Complex
  • antioxidant biofactor AOB
  • Aspirin